Pharmacy benefit managers face new, sweeping requirements to disclose all the different ways they get money from providing drug coverage.
The proposed rule from the Department of Labor published on Thursday would be a significant change for an industry that shields prescription drug data from employers and frequently locks its clients into restrictive contracts. Federal officials estimate the increased transparency could save employers and workers $1 billion annually as they have access to lower drug prices and actually take their medications.
Employers and governments hire PBMs to negotiate drug prices, create lists of covered drugs, build networks of pharmacies, and process drug claims. Labor attorneys, watchdogs, and even workers have warned large employers that they are overpaying for drugs.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
View All Plans
To read the rest of this story subscribe to STAT+.
Subscribe
<
Leave a Reply